Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950123-08-014781
Filing Date
2008-11-07
Accepted
2008-11-07 16:20:28
Documents
3
Effectiveness Date
2008-11-07

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS y72507defa14a.htm DEFA14A 11881
2 GRAPHIC y72507y7250701.gif GRAPHIC 4729
3 GRAPHIC y72507y7250702.gif GRAPHIC 6619
  Complete submission text file 0000950123-08-014781.txt   29306
Mailing Address 225 SUMMIT AVE MONTVALE NJ 07645-1523
Business Address 225 SUMMIT AVE MONTVALE NJ 07645-1523 201-930-3300
BARR PHARMACEUTICALS INC (Filer) CIK: 0000010081 (see all company filings)

EIN.: 221927534 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-09860 | Film No.: 081171674
SIC: 2834 Pharmaceutical Preparations